Patterns of expression of tumor necrosis factor α, tumor necrosis factor β, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy
Open Access
- 1 October 1996
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 39 (10) , 1703-1710
- https://doi.org/10.1002/art.1780391013
Abstract
Objective. To assess the expression of tumor necrosis factor α (TNF α), TNF β, and their receptors in synovia of patients with juvenile rheumatoid arthritis (JRA) and juvenile spondylarthropathy (JSpA), and to determine similarities with and differences from adult RA. Methods. Twenty-eight synovial tissue samples from patients with JRA, 6 from patients with JSpA, and 6 from patients with RA, selected for the presence of inflammatory infiltrates, were analyzed for the expression of TNF α, TNF β, and their receptors (p55 and p75 TNFR), utilizing the dual approach of reverse transcriptase—polymerase chain reaction and immunohistochemistry analysis. Results. The presence of both TNF α and TNF β expression was demonstrated in most JRA and JSpA tissues, although samples from patients with pauci-articular JRA had somewhat lesser amounts of these cytokines. TNF β expression correlated significantly with the occurrence of lymphocytic aggregates in tissues. Staining with monoclonal antibodies specific for the p55 and p75 receptors revealed that a diverse range of cell types expressed the receptors, with the most intense p55 staining on vascular endothelial cells. In the vast majority of synovial tissues, far greater numbers of cells expressed the p55 form of the receptor than the p75 form. Conclusion. JRA and JSpA synovia are characterized by the presence of TNF α, TNF β, and cells expressing TNFR. These findings provide further evidence that TNF, through autocrine/paracrine mechanisms, may amplify local inflammation, leading to joint destruction. The prominence of TNF β in the synovium in particular subgroups of JRA patients and in JSpA patients may be a distinguishing feature of these diseases.Keywords
This publication has 27 references indexed in Scilit:
- THE THERAPEUTIC EFFECTS OF AN ENGINEERED HUMAN ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY (CDP571) IN RHEUMATOID ARTHRITISRheumatology, 1995
- A Lymphotoxin-β-Specific ReceptorScience, 1994
- Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in LymphotoxinScience, 1994
- Adhesion of peripheral blood lymphocytes of children with arthritis to human umbilical vein endothelial cellsClinical and Experimental Immunology, 1994
- An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.The Journal of Experimental Medicine, 1993
- TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?Rheumatology, 1992
- Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serumArthritis & Rheumatism, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Monocyte bone degradation: In vitro analysis of monocyte activity in patients with juvenile rheumatoid arthritisThe Journal of Pediatrics, 1986
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985